A Slovenian company that makes an antioxidant pill some media have dubbed an “elixir of youth” is threatening to file lawsuits against scientists who have publicly spoken out against the product, calling it insufficiently tested. The face-off has an added bit of complexity: one prominent Croatian scientist is criticising another who has endorsed the therapy.
Mićo Tatalović is a news editor at Research Professional News. He has previously worked as a science news editor at Nature, New Scientist, and SciDev.Net. In 2018, he completed the Knight Science Journalism Program at the Massachusetts Institute of Technology in Cambridge, US, where he researched the use of machine learning and artificial intelligence in science journalism. He is also immediate former chairman of the Association of British Science Writers, and a board member of the European Federation for Science Journalism.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.